Categories: The Charlton Centre

COVID-19 Vaccination Weekly Forum

This week we are happy to share a great learning opportunity. COVID Discussions is a weekly meeting where a group of Canadian health professionals with expertise in vaccination offer weekly information sessions to answer questions from both the public and health professionals on COVID vaccination.  These health professionals volunteer their time for this excellent public service opportunity. The aim is to “provide a safe space for everyone to bring their questions about the science and social aspects of the COVID-19 pandemic.”1 The group meets from 8-10 EST on Mondays, Thursdays, and Saturdays.

Learn more and join the discussions here.

Carolyn Whiskin is the Pharmacy Manager for Charlton Health. Carolyn specializes in the treatment of autoimmune diseases, pharmaceutical compounding, women’s health, pain and smoking cessation. Carolyn has won provincial and national awards for her commitment to patient care and public service.

1 Fong, Bensun. “COVID Discussions”. COVID-19 Resources Canada, 2021, https://covid19resources.ca/public/discussions/.

admin

Recent Posts

Bimzelx Now Approved for Hidradenitis Suppurativa (HS)

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition that can be very painful and…

4 days ago

Happy Holidays from Charlton Health

As the year comes to a close, we wish you a joyful holiday season filled…

3 weeks ago

Winrevair: A New Treatment Option for Pulmonary Arterial Hypertension (PAH)

Pulmonary arterial hypertension occurs when there is increased pressure in the small blood vessels that…

1 month ago

New Biologic Treatment for PMR (Polymyalgia Rheumatica)

Polymyalgia rheumatica (PMR) is an inflammatory condition that causes widespread joint and muscle pain along…

2 months ago

Expanded Protection: RSV Vaccine Now Approved for More Adults

Respiratory Syncytial Virus (RSV) is a common virus that can cause serious lung infections, particularly in…

2 months ago

Rinvoq: A New Oral Option for Giant Cell Arteritis

Health Canada has recently approved Rinvoq (upadacitinib) for adults living with Giant Cell Arteritis (GCA). Rinvoq…

3 months ago